Flibanserin

On Tuesday, the FDA approved Flibanserin, a product developed by privately held Sprout Pharmaceuticals, as the first pharmacologic therapy for female sexual dysfunction. However, clinical evidence supporting the approval is limited, and the consent comes with a Black Box warning, REMS, and three...